James R.Wooley (Jim)

Partner

Cleveland + 1.216.586.7345

Jim Wooley, a trial attorney and former federal prosecutor, represents businesses and individuals in high-stakes government investigations, criminal litigation, and commercial disputes. He also conducts internal investigations into allegations of corruption, fraud, and other misconduct.

Jim's matters involve antitrust, health care fraud, securities fraud, public corruption, environmental crimes, customs law violations, and other criminal statutes. He regularly conducts global internal investigations related to potential fraud and FCPA violations. He has successfully represented clients in matters before the U.S. Department of Justice, as well as the SEC, DEA, EPA, FDA, OFAC, and other federal, state, and local agencies.

At the DOJ, Jim handled cases involving racketeering, public corruption, murder, fraud, money laundering, and other federal crimes. He received awards for his work prosecuting notable cases, including RICO cases against organized crime families, the landmark forensic DNA case in the U.S., and the largest police corruption case in FBI history at that time. He also served as an Assistant D.A. in Manhattan D.A. Robert Morgenthau's office.

Jim is a Fellow of the American College of Trial Lawyers. He has been appointed to chair the selection committee for the Federal Defender for the Northern District of Ohio, to act as special prosecutor in cases alleging prosecutorial misconduct, to oversee an audit of the Cleveland Police Department Crime Laboratory, and to investigate allegations of fraud within the Cleveland City School District. He is a member of the Public Defender Commission for Cuyahoga County (Cleveland).

Jim was an adjunct professor at Case Western Reserve law school, teaching advanced criminal procedure for 20 years.

Experience

Weltman wins complete defense verdict in litigation brought by Consumer Financial Protection Bureau
Jones Day client Weltman, Weinberg & Reis Co., LPA ("Weltman") secured a complete defense verdict in litigation brought by the Consumer Financial Protection Bureau ("CFPB").

Hyster-Yale acquires 75 percent of Zhejiang Maximal Forklift Truck
Jones Day advised Hyster-Yale Materials Handling, Inc. in its $90 million acquisition of 75 percent of the outstanding shares of, and a controlling interest in, Zhejiang Maximal Forklift Company Limited from KNSN Pipe and Pile Company Limited.

Owens Corning issues $600 million of 4.300% Senior Notes in public offering
Jones Day represented Owens Corning, a global developer and producer of insulation, roofing, and fiberglass composites, in connection with its underwritten public offering of $600 million aggregate principal amount of 4.300% Senior Notes due 2047.

Board of Trustees conducts internal investigation into allegations that football program covered up sexual assault incidents
Jones Day was retained by the Board of Trustees of a national university to conduct an internal investigation into whether the university's Division 1 football program violated university policy and other laws by covering up incidents of sexual assault involving football players.

Auto parts manufacturer investigated by federal authorities for involvement in issues relating to unsafe vehicle operations
Jones Day represented an auto parts manufacturer in investigations conducted by the DOJ, SEC and NHTSA into whether the client and other automotive companies committed violations in connection with alleged unsafe acceleration of vehicles.

Multinational company reports results of internal investigation of alleged FCPA violations to SEC, which takes no action
On behalf of a multinational company doing business in oil and gas in the Asia-Pacific, South America, and Mexico, Jones Day conducted an internal investigation into allegations of corrupt payments made to procure business.

Owens Corning issues $400 million of 3.400% Senior Notes in public offering
Jones Day represented Owens Corning, a global developer and producer of insulation, roofing, and fiberglass composites, in connection with its underwritten public offering of $400 million aggregate principal amount of 3.400% Senior Notes due 2026.

Independent living facility chain resolves FCA investigation
Jones Day represented a national chain of independent living facilities in a False Claims Act case involving whether the company facilitated residents in abusing a Veterans Administration program to obtain funds to cover their rents.

Custodial bank successfully defends against Department of Justice pay-to-play investigation
Jones Day successfully represented a custodial bank in a Department of Justice investigation involving pay-to-play allegations related to the bank's contract with a state treasurer to hold billions of dollars in public pension assets.

Sherwin-Williams issues $800 million of Senior Notes in public offering
Jones Day represented The Sherwin-Williams Company, a leading global developer, manufacturer, distributor and retailer of paint, coatings and related products, in connection with its issuance of $400 million aggregate principal amount of 3.450% Senior Notes due 2025 and $400 million aggregate principal amount of 4.55% Senior Notes due 2045 in a public offering.

Cardinal Health obtains dismissal of suit alleging pharmaceutical companies contributed to "epidemic of prescription drug abuse"
Jones Day client Cardinal Health, Inc. obtained dismissal of a lawsuit filed by Fulton County, Georgia that alleged Cardinal Health and other pharmaceutical distribution companies were to blame for a growing prescription-drug epidemic.

Sherwin-Williams acquires the U.S./Canada business of Comex for $165 million
Jones Day advised The Sherwin-Williams Company in its acquisition of the U.S./Canada business of Consorcio Comex, S.A. de C.V., a leader in the paint and coatings market in Mexico, for $165 million.

Jones Day represents Cleveland kidnapping survivors on pro bono basis
The Firm is representing on a pro bono basis Amanda Berry, her minor daughter, and Gina DeJesus, three of the survivors in the Cleveland kidnapping and captivity case uncovered in early May.

Business owner undergoes industry wide corruption probe and negotiates favorable plea agreement
Jones Day represented a business owner in an industry wide corruption probe in which several targets were convicted of bribery and sentenced to multiple year prison terms.

Chemical manufacturing company conducts internal investigation into allegations head of foreign sales office paid bribes to customers and embezzled substantial monies
Jones Day, on behalf of a chemical manufacturing company, conducted an internal investigation of allegations the head of foreign sales office paid bribes to customers and embezzled substantial monies from the company.

Chemical manufacturing company obtains No Action Letter from OFAC after investigation of alleged indirect shipments into Iran through foreign sales offices in violation of embargo
Jones Day, on behalf of a chemical manufacturing company, obtained a No Action Letter from OFAC after investigation of alleged indirect shipments into Iran through foreign sales offices in violation of embargo.

Healthcare services company conducts internal investigation into allegations that company knowingly purchased pharmaceutical products from alternative source vendors lacking proper registration and in subsequent DOJ/FDA investigation
Jones Day, on behalf of a healthcare services company, conducted an internal investigation of allegations that the company knowingly purchased pharmaceutical products from alternative source vendors who lacked proper registration.

Healthcare services company conducts internal investigation into alleged anticompetitive activity and DOJ investigation
Jones Day, on behalf of a healthcare services company, conducted an internal investigation of alleged anticompetitive activity and successfully represented company in subsequent DOJ investigation of same.

Healthcare services company conducts internal investigation of allegations of retaliation against former employee in SEC accounting fraud investigation and obtains declination from OSHA
Jones Day, on behalf of a healthcare services company, conducted an internal investigation of allegations of retaliation against former employee who alleged he was discharged for cooperating in SEC accounting fraud investigation.

International manufacturing company avoids charges in joint DOJ/SEC investigation of alleged corruption in connection with operations in Asia Pacific region
Jones Day successfully represented an international manufacturing company in a joint DOJ/SEC investigation of alleged corruption in connection with operations in Asia Pacific region.

Additional Publications

  • April 2018France Takes Next Step in Anticorruption Enforcement: First "French DPAs" and What Companies Should Know
  • April 2018French Anti-Corruption Agency Publishes Information Expected from Companies During Agency Inspections
  • November 2017DOJ's New FCPA Enforcement Policy Continues its "Carrot-and-Stick" Approach
  • February 2017Department of Justice Fraud Section Provides Guidance on Evaluating Corporate Compliance Programs
  • January 2017A New Era in French Anticorruption Enforcement: What Companies Should Know About the Newly Enacted Sapin II Law
  • January 2017FCPA 2016 Year in Review
  • April 2016Department of Justice FCPA Pilot Program Outlines Incentives for Corporate Self-Disclosure and Cooperation: What's New and Will It Matter?
  • January 2016FCPA 2015 Year In Review
  • September 2015U.S. Department of Justice Announces Updated Guidelines on Individual Accountability for Corporate Wrongdoing
  • March 2015Revisiting My Brother's Keeper: Latest Learning and Best Practices on Dealings with Third Parties under the FCPA
  • February 2015FCPA Year in Review: 2014
  • January 2015Expecting the Unexpected: How to Prepare for, Respond to, and Survive a Search Warrant
  • July 2014In re: Kellogg Brown & Root, Inc., et al.: D.C. Circuit Grants Petition for Mandamus and Protects Attorney–Client Privilege of Internal Investigation in False Claims Act Case
  • March 2014Recent Order from D.C. District Court Forces Defendants to Produce Results of Internal Investigations Finding Attorney-Client and Attorney Work Product Privileges Not Applicable
  • March 2013District Court Rules FCPA Jurisdiction Has Limits
  • January 2013Corporate Internal Investigations: Best Practices, Pitfalls to Avoid
  • December 2012DOJ/SEC's Resource Guide to the U.S. Foreign Corrupt Practices Act: Jones Day Summary and Analysis
  • May 2009Conducting an Effective Internal Corporate Investigation: Best Practices, Pitfalls to Avoid

Speaking Engagements

  • December 3, 2013A Civil Action: The Civil Implications of a Criminal Investigation, Jones Day CLE Academy 2013
We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.